Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-05 Sale | 2023-04-07 9:02 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $108.42 | $1,084,200 | 102,851 (Direct) | View |
| 2023-03-15 Sale | 2023-03-17 9:02 pm | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 25,000 | $116.14 | $2,903,500 | 338,777 (Direct) | View |
| 2023-03-06 Sale | 2023-03-08 9:33 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $122.13 | $1,221,300 | 112,851 (Direct) | View |
| 2023-03-08 Sale | 2023-03-08 9:30 pm | Prometheus Biosciences Inc. | RXDX | Cedars Sinai Intellectual Property Co 10% Owner | 865,000 | $114.59 | $99,120,350 | 4,001,132 (Indirect) | View |
| 2023-03-01 Sale | 2023-03-03 9:30 pm | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 11,320 | $125.14 | $1,416,563 | 1,029,214 (Direct) | View |
| 2023-02-15 Sale | 2023-02-17 9:34 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $119.38 | $596,900 | 122,851 (Direct) | View |
| 2023-02-15 Sale | 2023-02-17 9:31 pm | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 63,680 | $120.82 | $7,693,618 | 1,363,547 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 8:42 pm | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $119 | $595,000 | 127,851 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 8:39 pm | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 25,000 | $118.99 | $2,974,750 | 388,777 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-04-13 | Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director | 62,571 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-04-13 | Prometheus Biosciences Inc. | RXDX | Laur James Director | 62,571 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2028-05-22 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 497,792 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-03-10 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 62,571 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2029-11-06 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President and CEO | 2,205,545 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-02-04 | Prometheus Biosciences Inc. | RXDX | Swain Judith L Director | 52,571 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2030-08-24 | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 106,986 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-05-13 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 63,677 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2030-08-11 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 605,506 | $0 | 0 (Direct) | View |
| 2023-06-16 Disposition | 2023-06-16 4:00 pm | N/A 2031-02-04 | Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director | 55,283 | $0 | 0 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 7:13 pm | N/A 2029-11-06 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 122,531 | $0 | 471,882 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 7:13 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 122,528 | $2.9 | 471,882 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 7:13 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 3 | $1.7 | 471,882 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 7:03 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 78,162 | $3.1 | 140,811 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-02 7:03 pm | N/A 2030-08-11 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 78,162 | $0 | 140,811 (Direct) | View |
| 2023-06-01 Other | 2023-06-02 6:57 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 14,000 | $0 | 54,708 (Direct) | View |
| 2023-06-02 Other | 2023-06-02 6:43 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 10,000 | $0 | 37,278 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:47 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 2,071 | $0 | 2,071 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:45 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Swain Judith L Director | 2,071 | $0 | 2,071 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:44 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 2,278 | $0 | 17,278 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:42 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Laur James Director | 2,071 | $0 | 2,071 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:41 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director | 2,071 | $0 | 2,071 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:39 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 2,123 | $0 | 2,123 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-19 5:38 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Adams Helen C. Director | 2,174 | $0 | 2,674 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 9:02 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $3.7 | 102,851 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 9:02 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $0 | 102,851 (Direct) | View |
| 2023-03-15 Exercise | 2023-03-17 9:02 pm | N/A 2029-11-06 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 25,000 | $0 | 338,777 (Direct) | View |
| 2023-03-15 Exercise | 2023-03-17 9:02 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 25,000 | $2.9 | 338,777 (Direct) | View |
| 2023-03-06 Exercise | 2023-03-08 9:33 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $3.7 | 112,851 (Direct) | View |
| 2023-03-06 Exercise | 2023-03-08 9:33 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 10,000 | $0 | 112,851 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 9:30 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 11,320 | $3.7 | 1,029,214 (Direct) | View |
| 2023-03-01 Exercise | 2023-03-03 9:30 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 11,320 | $0 | 1,029,214 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 9:34 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $3.7 | 122,851 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 9:34 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $0 | 122,851 (Direct) | View |
| 2023-02-16 Exercise | 2023-02-17 9:31 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 38,680 | $3.7 | 1,363,547 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 9:31 pm | N/A 2029-11-06 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 63,680 | $0 | 1,363,547 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 9:31 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 25,000 | $2.9 | 1,363,547 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:42 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $3.7 | 127,851 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:42 pm | N/A 2030-12-17 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 5,000 | $0 | 127,851 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:39 pm | N/A 2029-11-06 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 25,000 | $0 | 388,777 (Direct) | View |
| 2023-01-17 Exercise | 2023-01-19 8:39 pm | N/A N/A | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 25,000 | $2.9 | 388,777 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 8:19 pm | N/A 2032-12-15 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 12,920 | $0 | 12,920 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:38 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | Stenhouse Mark Chief Operating Officer | 43,896 | $0 | 60,527 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:35 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | Marshall Keith W Chief Financial Officer | 43,896 | $0 | 43,896 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:32 pm | N/A 2032-12-08 | Prometheus Biosciences Inc. | RXDX | McKenna Mark C. Chairman, President & CEO | 166,043 | $0 | 184,074 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:30 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Szela Mary T Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:28 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Swain Judith L Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:26 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | PAPA JOSEPH C Director | 22,551 | $0 | 22,551 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:24 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Laur James Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:22 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Hendrix Martin Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-20 7:20 pm | N/A 2032-05-18 | Prometheus Biosciences Inc. | RXDX | Hassan Fred Director | 21,013 | $0 | 21,013 (Direct) | View |